Aevi Genomic Medicine Inc (NASDAQ:GNMX)

1.22
Delayed Data
As of 1:49pm ET
 -0.02 / -1.61%
Today’s Change
1.01
Today|||52-Week Range
2.65
+1.67%
Year-to-Date
No recent news for Aevi Genomic Medicine Inc.

Today’s Trading

Previous close1.24
Today’s open1.26
Day’s range1.20 - 1.27
Volume68,527
Average volume (3 months)130,908
Market cap$89.6M
Data as of 1:49pm ET, 06/18/2018

Growth & Valuation

Earnings growth (last year)+30.25%
Earnings growth (this year)+26.10%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.93

Competitors

 Today’s
change
Today’s
% change
INFIInfinity Pharmaceuti...-0.12-6.25%
JNPJuniper Pharmaceutic...-0.10-1.14%
ATNMActinium Pharmaceuti...+0.05+10.24%
SNSSSunesis Pharmaceutic...+0.09+4.27%
Data as of 2:04pm ET, 06/18/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$0.00
Annual profit (last year)-$34.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael F. Cola
Chief Financial &
Accounting Officer, Secretary
Brian D. Piper
Corporate headquarters
Wayne, Pennsylvania

Forecasts